Skip to main content

Table 1 TGF-β1, PDGF and proBNP levels in the whole study population

From: Transforming growth factor beta 1 levels predict echocardiographic changes at three years after adjuvant radiotherapy for breast cancer

  

Before RT

After RT

Three years

   

n

Md

IQR

Md

IQR

Md

IQR

p1

p2

p3

TGF-β1 (ng/ml)

63

19.2

(17.1–22.3)

18.8

(14.5–22.0)

17.2

(13.7–21.2)

0.003

0.001

0.101

PDGF (ng/ml)

63

15.4

(12.6–19.1)

13.8

(11.7–16.2)

15.6

(10.4–18.4)

0.001

0.046

0.661

proBNP (ng/l)

62

75.5

(42.5–125.5)

75.0

(35.5–132.8)

101.0

(55.5–183.3)

0.325

< 0.001

< 0.001

  1. TGF-β1 Transforming growth factor beta 1, PDGF Platelet-derived growth factor, proBNP N-terminal pro-brain natriuretic peptide, RT Radiotherapy, Md Median, IQR Interquartile range, p1 Change from before to after RT, p2 Change from before to 3 years after RT, p3 Change from after RT to 3 years after RT